{"id":404593,"date":"2020-12-22T10:03:28","date_gmt":"2020-12-22T15:03:28","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=404593"},"modified":"2020-12-22T10:03:28","modified_gmt":"2020-12-22T15:03:28","slug":"pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/","title":{"rendered":"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts<\/b><\/p>\n<p>NEW YORK&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nPfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, February 2, 2021. The purpose of the call is to provide an update on Pfizer\u2019s results, as reflected in the company\u2019s Fourth Quarter and Full Year 2020 Performance Report, to be issued that morning.\n<\/p>\n<p>\nTo view and listen to the webcast and view the Performance Report, visit our web site at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pfizer.com%2Finvestors&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=www.pfizer.com%2Finvestors&amp;index=1&amp;md5=709c3789c0f759adff8145cfc1e93dd9\">www.pfizer.com\/investors<\/a>. Information on accessing and pre-registering for the webcast will be available at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pfizer.com%2Finvestors&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=www.pfizer.com%2Finvestors&amp;index=2&amp;md5=7a5854752cf1d1e38448dcb7346da6a6\">www.pfizer.com\/investors<\/a> beginning today. Participants are advised to register in advance of the conference call.\n<\/p>\n<p>\nYou can also listen to the conference call by dialing either (866) 662-3198 in the United States and Canada or (918) 922-6130 outside of the United States and Canada. The password is \u201cFourth Quarter Earnings\u201d.\n<\/p>\n<p>\nVisitors to <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pfizer.com%2Finvestors&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=www.pfizer.com%2Finvestors&amp;index=3&amp;md5=3398bb54405a58f880fc9d1aef7843b5\">www.pfizer.com\/investors<\/a> will be able to view and listen to an archived copy of the webcast of the conference call.\n<\/p>\n<p><b><i>About Pfizer: Breakthroughs That Change Patients\u2019 Lives<\/i><\/b><\/p>\n<p>\nAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world&#8217;s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pfizer.com%2F&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=www.Pfizer.com&amp;index=4&amp;md5=a458837ff144c43a4abeef165901f06b\">www.Pfizer.com<\/a>. In addition, to learn more, please visit us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pfizer.com%2F&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=www.Pfizer.com&amp;index=5&amp;md5=18c7680939c3d359a07e8cfd0b7bc61d\">www.Pfizer.com<\/a> and follow us on Twitter at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fpfizer&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=%40Pfizer&amp;index=6&amp;md5=eed5ab8c7532cfe1d4340e60e25706b8\">@Pfizer<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fpfizer_news&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=%40Pfizer+News&amp;index=7&amp;md5=d7d35d597ec762622dc83bbcbf0c7387\">@Pfizer News<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fpfizer&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=8&amp;md5=dfa23a84af12379b068d616fe65b08ab\">LinkedIn<\/a>, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fpfizer&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=YouTube&amp;index=9&amp;md5=87c1c7be33c5092565cd0f9435e06aee\">YouTube<\/a> and like us on Facebook at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FPfizer%2F&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=Facebook.com%2FPfizer&amp;index=10&amp;md5=2e5ee0ee85633c8a737932ad1ea860bc\">Facebook.com\/Pfizer<\/a>.\n<\/p>\n<p><b><i>Disclosure Notice:<\/i><\/b><i>The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance; business plans and prospects; expectations for our product pipeline; in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, revenue contribution, growth, performance, timing of exclusivity and potential benefits; manufacturing and product supply; our efforts to respond to COVID-19, including our vaccine against SARS-CoV-2 and our investigational protease inhibitor; our expectations regarding the impact of COVID-19; our ability to successfully capitalize on growth opportunities and prospects; plans for and prospects of our acquisitions and other business development activities, including the combination of Upjohn with Mylan N.V. to create a new global pharmaceutical company, Viatris; and plans relating to share repurchases and dividends, among other things, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer\u2019s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned \u201cRisk Factors\u201d and \u201cForward-Looking Information and Factors That May Affect Future Results\u201d, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=11&amp;md5=cce250455b12d8964c2c4941be8416c3\">www.sec.gov<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pfizer.com&amp;esheet=52351455&amp;newsitemid=20201222005012&amp;lan=en-US&amp;anchor=www.pfizer.com&amp;index=12&amp;md5=05ad6fee1d79ede06966c2e2eea7e666\">www.pfizer.com<\/a>.<\/i><\/p>\n<p><i>The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.<\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201222005012\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201222005012\/en\/<\/a><\/span><\/p>\n<p><span style=\"font-weight:normal\">Media Relations:<br \/>\n<\/span><br \/><span style=\"font-weight:normal\">Amy Rose<br \/>\n<\/span><br \/><span style=\"font-weight:normal\">+1 (646) 592-3157<br \/>\n<\/span><br \/><a rel=\"nofollow\" href=\"mailto:Amy.Rose@Pfizer.com\"><span style=\"font-weight:normal\">Amy.Rose@Pfizer.com<\/span><\/a><span style=\"font-weight:normal\" \/><\/p>\n<p><span style=\"font-weight:normal\">Investor Relations:<br \/>\n<\/span><br \/><span style=\"font-weight:normal\">Bryan Dunn<br \/>\n<\/span><br \/><span style=\"font-weight:normal\">+1 (212) 733-8917<br \/>\n<\/span><br \/><a rel=\"nofollow\" href=\"mailto:Bryan.Dunn@Pfizer.com\"><span style=\"font-weight:normal\">Bryan.Dunn@Pfizer.com<\/span><\/a><span style=\"font-weight:normal\" \/><\/p>\n<p><b>KEYWORDS:<\/b> United States North America New York<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Infectious Diseases Clinical Trials Research Science Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201222005012\/en\/337677\/3\/pfizer_rgb_pos.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts NEW YORK&#8211;(BUSINESS WIRE)&#8211; Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, February 2, 2021. The purpose of the call is to provide an update on Pfizer\u2019s results, as reflected in the company\u2019s Fourth Quarter and Full Year 2020 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com\/investors. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com\/investors beginning today. Participants are advised to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-404593","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts NEW YORK&#8211;(BUSINESS WIRE)&#8211; Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, February 2, 2021. The purpose of the call is to provide an update on Pfizer\u2019s results, as reflected in the company\u2019s Fourth Quarter and Full Year 2020 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com\/investors. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com\/investors beginning today. Participants are advised to &hellip; Continue reading &quot;Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-22T15:03:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts\",\"datePublished\":\"2020-12-22T15:03:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/\"},\"wordCount\":713,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/\",\"name\":\"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-12-22T15:03:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/","og_locale":"en_US","og_type":"article","og_title":"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts - Market Newsdesk","og_description":"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts NEW YORK&#8211;(BUSINESS WIRE)&#8211; Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, February 2, 2021. The purpose of the call is to provide an update on Pfizer\u2019s results, as reflected in the company\u2019s Fourth Quarter and Full Year 2020 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com\/investors. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com\/investors beginning today. Participants are advised to &hellip; Continue reading \"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-22T15:03:28+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts","datePublished":"2020-12-22T15:03:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/"},"wordCount":713,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/","name":"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-12-22T15:03:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201222005012r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-2-conference-call-with-analysts\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/404593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=404593"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/404593\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=404593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=404593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=404593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}